Emergent BioSolutions
EBS
#8517
Rank
NZ$0.47 B
Marketcap
NZ$9.29
Share price
-1.17%
Change (1 day)
-47.26%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): NZ-$8.86

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is NZ-$9.20. In 2025 the company made an earnings per share (EPS) of NZ$1.73 an increase over its 2024 EPS that were of NZ-$6.63.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$8.86-610.72%
2025NZ$1.73-126.17%
2024NZ-$6.63-75.61%
2023NZ-$27.16232.21%
2022NZ-$8.18-203.46%
2021NZ$7.90-25.09%
2020NZ$10.55445.28%
2019NZ$1.93-15.2%
2018NZ$2.28-35.9%
2017NZ$3.5669.57%
2016NZ$2.10-27.67%
2015NZ$2.9065.62%
2014NZ$1.7511.63%
2013NZ$1.5732.31%
2012NZ$1.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.30-114.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.81-119.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.25-157.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ-$3.29-64.29%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.97-110.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.94-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$0.82-108.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel